Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Locoregional prostate cancer treatment pattern variation in independent cancer centers: policy effect, patient preference, or physician incentive?

Camarata AS, Nickleach DC, Jani AB, Rossi PJ.

Health Serv Insights. 2015 Apr 15;8:1-8. doi: 10.4137/HSI.S24092. eCollection 2015.

2.

Bladder preservation strategies.

Jani AB, Efstathiou JA, Shipley WU.

Hematol Oncol Clin North Am. 2015 Apr;29(2):289-300, ix. doi: 10.1016/j.hoc.2014.10.004. Epub 2014 Dec 15. Review.

PMID:
25836935
3.

Role of radiation and androgen deprivation therapy for advanced prostate cancer.

Jani AB, Rossi PJ.

Curr Probl Cancer. 2015 Jan-Feb;39(1):41-7. doi: 10.1016/j.currproblcancer.2014.11.007. Epub 2014 Nov 25. No abstract available.

PMID:
25554467
4.

Video-based educational tool improves patient comprehension of common prostate health terminology.

Wang DS, Jani AB, Sesay M, Tai CG, Lee DK, Echt KV, Goodman MG, Kilbridge KE, Master VA.

Cancer. 2015 Mar 1;121(5):733-40. doi: 10.1002/cncr.29101. Epub 2014 Nov 12.

PMID:
25393416
5.

Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy.

Yang X, Rossi P, Ogunleye T, Marcus DM, Jani AB, Mao H, Curran WJ, Liu T.

Med Phys. 2014 Nov;41(11):111915. doi: 10.1118/1.4897615.

PMID:
25370648
6.

Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis.

Odewole OA, Oyenuga OA, Tade F, Savir-Baruch B, Nieh PT, Master V, Chen Z, Wang X, Jani AB, Bellamy LM, Halkar RK, Goodman MM, Schuster DM.

Mol Imaging Biol. 2015 Apr;17(2):277-83. doi: 10.1007/s11307-014-0797-1.

PMID:
25281411
7.

The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer.

Marcus DM, Rossi PJ, Nour SG, Jani AB.

Urology. 2014 Jul;84(1):132-7. doi: 10.1016/j.urology.2014.03.012. Epub 2014 Apr 29.

PMID:
24785987
8.

Clinically Significant Difference in Prostate Localization Using Daily Cone Beam CT (CBCT) and Electromagnetic Transponders.

Khan MK, Das S, Ogunleye T, Jani AB, Rossi P, Shelton J, Liu T.

Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1):S15. doi: 10.1016/j.prro.2013.01.056. Epub 2013 Mar 25. No abstract available.

PMID:
24674493
9.

Reduced acute toxicity associated with the use of volumetric modulated arc therapy for the treatment of adenocarcinoma of the prostate.

Hall WA, Colbert L, Nickleach D, Shelton J, Marcus DM, Switchenko J, Rossi PJ, Godette K, Cooper S, Jani AB.

Pract Radiat Oncol. 2013 Oct-Dec;3(4):e157-64. doi: 10.1016/j.prro.2013.01.003. Epub 2013 Feb 21.

PMID:
24674413
10.

A New CT Prostate Segmentation for CT-Based HDR Brachytherapy.

Yang X, Rossi P, Ogunleye T, Jani AB, Curran WJ, Liu T.

Proc SPIE Int Soc Opt Eng. 2014;9036:90362K.

11.

Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.

Schuster DM, Nieh PT, Jani AB, Amzat R, Bowman FD, Halkar RK, Master VA, Nye JA, Odewole OA, Osunkoya AO, Savir-Baruch B, Alaei-Taleghani P, Goodman MM.

J Urol. 2014 May;191(5):1446-53. doi: 10.1016/j.juro.2013.10.065. Epub 2013 Oct 19.

12.

The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate.

Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB.

Cancer. 2013 Sep 15;119(18):3272-9. doi: 10.1002/cncr.28185. Epub 2013 Jul 1.

13.

Therapeutic options for a rising PSA after radical prostatectomy.

Carthon BC, Marcus DM, Herrel LA, Jani AB, Rossi PJ, Canter DJ.

Can J Urol. 2013 Jun;20(3):6748-55. Review.

14.

Influence of vascular comorbidities and race on erectile dysfunction after prostate cancer radiotherapy.

Wang Y, Liu T, Rossi PJ, Watkins-Bruner D, Hsiao W, Cooper S, Yang X, Jani AB.

J Sex Med. 2013 Aug;10(8):2108-14. doi: 10.1111/jsm.12215. Epub 2013 Jun 6.

15.

Severe lack of comprehension of common prostate health terms among low-income inner-city men.

Wang DS, Jani AB, Tai CG, Sesay M, Lee DK, Goodman M, Echt KV, Kilbridge KE, Master VA.

Cancer. 2013 Sep 1;119(17):3204-11. doi: 10.1002/cncr.28186. Epub 2013 Jun 3.

16.

Comparison of image-guided radiotherapy technologies for prostate cancer.

Das S, Liu T, Jani AB, Rossi P, Shelton J, Shi Z, Khan MK.

Am J Clin Oncol. 2014 Dec;37(6):616-23. doi: 10.1097/COC.0b013e31827e4eb9. Review.

PMID:
23428948
17.

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy.

Ali AN, Rossi PJ, Godette KD, Martin D, Liauw S, Vijayakumar S, Cooper S, Jani AB.

Pract Radiat Oncol. 2013 Jan-Mar;3(1):e1-9. doi: 10.1016/j.prro.2012.04.005. Epub 2012 May 10.

PMID:
24674267
18.

Treatment efficiency of volumetric modulated arc therapy in comparison with intensity-modulated radiotherapy in the treatment of prostate cancer.

Hall WA, Fox TH, Jiang X, Prabhu RS, Rossi PJ, Godette K, Jani AB.

J Am Coll Radiol. 2013 Feb;10(2):128-34. doi: 10.1016/j.jacr.2012.06.014. Epub 2012 Dec 12.

PMID:
23245437
19.

Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk.

Marcus DM, Jani AB, Rossi PJ.

Cancer. 2013 Mar 15;119(6):1284. doi: 10.1002/cncr.27879. Epub 2012 Dec 11. No abstract available.

20.

Salvage therapy for locally recurrent prostate cancer after radiation.

Marcus DM, Canter DJ, Jani AB, Dobbs RW, Schuster DM, Carthon BC, Rossi PJ.

Can J Urol. 2012 Dec;19(6):6534-41. Review.

PMID:
23228288
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk